Postneoadjuvant Chemotherapy Response in Advanced Ovarian Cancer: Radiological and Clinical Implications-Reference-Cited by-同舟云学术

Postneoadjuvant Chemotherapy Response in Advanced Ovarian Cancer: Radiological and Clinical Implications

Published:2020-07 Issue:7 Volume:27 Page:958-959
ISSN:1076-6332
Container-title:Academic Radiology
language:en
Short-container-title:Academic Radiology

Author:

Shampain Kimberly L.^ORCID,Wasnik Ashish P.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging

Reference14 articles.

1. Neoadjuvant chemotherapy versus primary debulking surgery in advanced epithelial ovarian cancer: a meta-analysis of peri-operative outcome;Yang;PLoS One,2017

2. Oncology FCoG. FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication;Prat;J Gynecol Oncol,2015

3. McGuire WP, Hoskins WJ, Brady MF, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with Stage III and Stage IV ovarian cancer. 1996;334:1–6.

4. Survival rates for international federation of gynecology and obstetrics stage III ovarian carcinoma by cell type: a study of 262 unselected patients with uniform pathologic review;Seidman;Int J Gynecol Cancer,2012

5. 2010 Gynecologic Cancer Inter Group (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference;Stuart;Int J Gynecol Cancer,2011

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy of TP chemotherapy combined with karelizumab on the postoperative clinical status of patients with advanced ovarian cancer;European Journal of Gynaecological Oncology;2023

2. Relationship Between Neoadjuvant Chemotherapy and Log Odds of Positive Lymph Nodes and Their Prognostic Role in Advanced Ovarian Cancer Patients With Optimal Cytoreductive Surgery;Frontiers in Oncology;2022-05-16